Nordic Pharma

Nordic Pharma

France - Paris
Diagnostics
WebsiteLinkedInCareers Page

Focus: Specialty Pharmaceuticals, Diagnostic, hyaluronic acid

Nordic Pharma is a life sciences company focused on Specialty Pharmaceuticals, Diagnostic, hyaluronic acid.

Metabolic Diseases
Funding Stage
PRIVATE
Open Jobs
0

Products & Portfolio (1)

1 discontinued product not shown

DDAVP
desmopressin acetate
LOE Approaching
INJECTION · INJECTABLE
Willebrand's disease Type I. The antidiuretic effects of desmopressin acetate are mediated by stimulation of vasopressin 2 (V2) receptors, thereby increasing water re-absorption in the kidney, and hence reducing urine production. Desmopressin acetate is a replacement hormone for antidiuretic hormone in the treatment of central diabetes insipidus. The change in structure of arginine vasopressin to desmopressin acetate resulted in increased duration of action and a decreased vasopressor action and decreased actions on visceral smooth muscle relative to the enhanced antidiuretic activity, so that clinically effective antidiuretic doses were usually below threshold levels for effects on vascular or visceral smooth muscle.
nephrogenic diabetes insipidusthere is evidence of an abnormal molecular form of factor VIII antigensevere von Willebrand's disease (Type I)+4 more
1984
30

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 2 approved products, 2 clinical trials
Top TAs: Metabolic Diseases, Oncology
Portfolio Health
Peak1 (50%)
LOE Approaching1 (50%)
2 total products
Therapeutic Area Focus
Oncology
1 pipeline
Marketed
Pipeline

Visa Sponsorship

H-1B Petitions (FY2023)
0
Approved
1
Denied
0%
Rate

Source: USCIS H-1B Employer Data Hub